TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34110712

Group type: EXPERIMENTAL
Intervention: Moderate-high intensity resistance and aerobic exercise intervention (n = 8)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group (n = 6)
Number of subjects: 14
Study: 34326299

Group type: EXPERIMENTAL
Intervention: tDCS
Number of subjects: 57

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 57
Study: 32458074

Group type: EXPERIMENTAL
Intervention: Waist-shaped interdental brush
Number of subjects: 10

Group type: COMPARATOR
Intervention: Straight interdental brush
Number of subjects: 10
Study: 32752228

Group type: EXPERIMENTAL
Intervention: Brief group cognitive behavioral therapy (BG-CBT) - six brief weekly sessions
Number of subjects: 56

Group type: COMPARATOR
Intervention: Conventional care (control group)
Number of subjects: 56
Study: 35572910

Group type: EXPERIMENTAL
Intervention: Early extubation combined with a physical training program
Number of subjects: 96

Group type: COMPARATOR
Intervention: Routine nursing intervention
Number of subjects: 96
Study: 33770739

Group type: EXPERIMENTAL
Intervention: Empathic caring (three face-to-face nursing counseling sessions)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 62
Study: 33220462

Group type: EXPERIMENTAL
Intervention: Bencycloquidium bromide (BCQB) 125 μg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Bencycloquidium bromide (BCQB) 250 μg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Bencycloquidium bromide (BCQB) 500 μg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Bencycloquidium bromide (BCQB) 750 μg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Bencycloquidium bromide (BCQB) 1125 μg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Bencycloquidium bromide (BCQB) 1500 μg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Bencycloquidium bromide (BCQB) 2000 μg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Bencycloquidium bromide (BCQB) 750 μg/d (multiple dose)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Bencycloquidium bromide (BCQB) 1000 μg/d (multiple dose)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 35501736

Group type: EXPERIMENTAL
Intervention: 6-thioguanine (6TG) at a low dose of 2.5–12.5 mg/m2/day, combined with reduced 6-mercaptopurine (6MP) starting dose of 50 mg/m2/day
Number of subjects: 778

Group type: COMPARATOR
Intervention: Methotrexate (MTX)/6-mercaptopurine (6MP) maintenance therapy
Number of subjects: 778
Study: 32620344

Group type: EXPERIMENTAL
Intervention: Atropine combined with orthokeratology (ACO)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Orthokeratology (OK)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Atropine
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control (placebo and single vision glasses)
Number of subjects: 154
Study: 36261768

Group type: EXPERIMENTAL
Intervention: Group behavioral weight loss intervention with privacy features (present or not), matching participants to group based on weight loss barriers (matched or not), and intervention format (online or in-person)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Individual format interventions
Number of subjects: 0
Study: 34280820

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise (EX)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Light-intensity control (CON)
Number of subjects: 35
Study: 35619218

Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RIC) with cuff pressure of 200 mm Hg, performed twice a day for seven consecutive days
Number of subjects: 558

Group type: COMPARATOR
Intervention: Sham-RIC with cuff pressure of 60 mm Hg, performed twice a day for seven consecutive days
Number of subjects: 558

Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RIC)
Number of subjects: 558

Group type: COMPARATOR
Intervention: Sham-RIC
Number of subjects: 558
Study: 33676151

Group type: EXPERIMENTAL
Intervention: Balint groups (intervention)
Number of subjects: 311

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 311
Study: 32067512

Group type: COMPARATOR
Intervention: 30 mg/kg deferasirox
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 20 mg omeprazole and 30 mg/kg deferasirox
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 400 mg vitamin E and 30 mg/kg deferasirox
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 420 mg silymarin and 30 mg/kg deferasirox
Number of subjects: 160
Study: 34230556

Group type: EXPERIMENTAL
Intervention: Screening invitations with imposed deadlines (short deadline with no incentive)
Number of subjects: 7711

Group type: EXPERIMENTAL
Intervention: Screening invitations with imposed deadlines (small financial incentive)
Number of subjects: 7711

Group type: EXPERIMENTAL
Intervention: Screening invitations with imposed deadlines (large declining financial incentive)
Number of subjects: 7711

Group type: COMPARATOR
Intervention: Control group (no deadlines)
Number of subjects: 7711
Study: 35821886

Group type: EXPERIMENTAL
Intervention: ADC value of stage IA CC
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: ADC value after second chemotherapy in effective patients
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: ADC value before treatment and after first chemotherapy in ineffective patients
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Diagnostic performance of ADC value to differentiate CC and normal cervix
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Omics model based on OSag-T2WI&OAx-T2FS
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Group model based on OAx-T1WI
Number of subjects: 101
Study: 33507924

Group type: EXPERIMENTAL
Intervention: Gamified interview format
Number of subjects: 1266
Study: 33171944

Group type: EXPERIMENTAL
Intervention: Dietary diversity intervention (not specified in detail)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Nutritional status assessment (anthropometry and biochemical markers)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Plasma zinc concentration measurement
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Plasma selenium concentration measurement
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Iron status assessment (serum ferritin and blood hemoglobin)
Number of subjects: 47
Study: 34911706

Group type: EXPERIMENTAL
Intervention: risankizumab 150 mg
Number of subjects: 964

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 964
Study: 32179952

Group type: EXPERIMENTAL
Intervention: Minimally invasive linear stapler technique for intrathoracic esophagogastrostomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional intrathoracic anastomosis
Number of subjects: 0
Study: 35125179

Group type: EXPERIMENTAL
Intervention: Ovulation induction/OS with timed intercourse (for polycystic ovary syndrome)
Number of subjects: 1650

Group type: EXPERIMENTAL
Intervention: Ovulation induction/OS with intrauterine insemination
Number of subjects: 1650

Group type: EXPERIMENTAL
Intervention: Gonadotropin use
Number of subjects: 1650

Group type: EXPERIMENTAL
Intervention: Predictive model for clinical pregnancy
Number of subjects: 1650

Group type: EXPERIMENTAL
Intervention: Predictive model for multiple pregnancy
Number of subjects: 1650

Group type: EXPERIMENTAL
Intervention: Factors predicting cumulative pregnancy rates
Number of subjects: 1650
Study: 32901379

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) using diode laser (980 nm, 0.3 W) for 10 seconds at six spots along the midpalatal suture during active and passive phases of rapid palatal expansion.
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group received sham irradiations with the laser in standby mode.
Number of subjects: 34
Study: 35144607

Group type: EXPERIMENTAL
Intervention: Telephone aftercare groups for family carers, 6 months duration
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Telephone aftercare groups for family carers
Number of subjects: 141

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 141
Study: 34791044

Group type: EXPERIMENTAL
Intervention: Totally extraperitoneal (TEP) repair
Number of subjects: 202

Group type: COMPARATOR
Intervention: Open anterior repair (modified Lichtenstein)
Number of subjects: 202
Study: 35241775

Group type: EXPERIMENTAL
Intervention: 3-day amoxicillin treatment
Number of subjects: 3000

Group type: COMPARATOR
Intervention: 5-day amoxicillin treatment
Number of subjects: 3000
Study: 33423594

Group type: EXPERIMENTAL
Intervention: Football Fitness group (FFG, n = 46)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (CON, n = 22)
Number of subjects: 68
Study: 36158727

Group type: EXPERIMENTAL
Intervention: Continuous care model (group consultation sessions, once every week, four sessions each 60‐90 min)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Normal cares (control group)
Number of subjects: 110
Study: 33837481

Group type: EXPERIMENTAL
Intervention: Moxibustion Robot (MR)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Manual Moxibustion (MM)
Number of subjects: 70
Study: 35488826

Group type: EXPERIMENTAL
Intervention: Imipenem/cilastatin/relebactam (IMI/REL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Piperacillin-tazobactam (PIP/TAZ)
Number of subjects: 0
Study: 35246775

Group type: EXPERIMENTAL
Intervention: Vermont Family Based Approach (VFBA)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 81
Study: 33653365

Group type: EXPERIMENTAL
Intervention: 1000 mg/day Vitamin C supplementation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (Control)
Number of subjects: 24
Study: 32048478

Group type: EXPERIMENTAL
Intervention: Spatial awareness training (SA training)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group (no SA training)
Number of subjects: 104
Study: 34203487

Group type: EXPERIMENTAL
Intervention: Hyaluronan (HA) 120 mg daily for 12 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 32362436

Group type: EXPERIMENTAL
Intervention: Incentive group ($10/day maximum for undetectable viral loads)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Usual Care group (no incentives)
Number of subjects: 102
Study: 32029044

Group type: EXPERIMENTAL
Intervention: PiCCO monitoring for hemodynamics
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional ECG monitoring and lung sound, urine volume
Number of subjects: 60
Study: 35215405

Group type: EXPERIMENTAL
Intervention: NMN (250 mg) administered once a day for 12 weeks
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo administered once a day for 12 weeks
Number of subjects: 108
Study: 34880007

Group type: EXPERIMENTAL
Intervention: Six-week rehabilitation programme using the activity pacing framework
Number of subjects: 107
Study: 34470137

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone (200 mg daily)
Number of subjects: 58

Group type: COMPARATOR
Intervention: 17-alpha-hydroxyprogesterone caproate (17OHP-C) (250 mg intramuscular weekly)
Number of subjects: 58
Study: 33148218

Group type: EXPERIMENTAL
Intervention: 12-week staff-led and expert-supported intervention
Number of subjects: 116
Study: 35201805

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Computerized CBT
Number of subjects: 94

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 94
Study: 33478533

Group type: EXPERIMENTAL
Intervention: Indoor residual spraying (IRS) with pirimiphos-methyl (PM)
Number of subjects: 10
Study: 32058364

Group type: EXPERIMENTAL
Intervention: Multi-ingredient beverage (MTN)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Carbohydrate alone (CHO)
Number of subjects: 10
Study: 33741236

Group type: EXPERIMENTAL
Intervention: Intensive voice therapy (1 hour, 4 days per week for 2 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Weekly voice therapy (1 hour per week for 8 weeks)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intensive voice therapy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Weekly voice therapy
Number of subjects: 20
Study: 33674897

Group type: EXPERIMENTAL
Intervention: Saponin extract from Sesbania grandiflora pods meal (SES) at 0.6% of total substrate on a dry matter basis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Saponin extract from Sesbania grandiflora pods meal (SES) at varying levels (0, 0.2, 0.4, and 0.6%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Crude protein levels at 14% and 16%
Number of subjects: 0
Study: 36089964

Group type: EXPERIMENTAL
Intervention: Closed home physical education teaching model based on big data technology and artificial intelligence algorithm
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional online physical education teaching methods
Number of subjects: 0
Study: 33246500

Group type: EXPERIMENTAL
Intervention: Barberry powder (BP; containing 10 g milled dried barberry and 1 g of milled sucrose)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo powder (PP; containing 9 g maltodextrin, 1 g citric acid, 1 g milled sucrose and edible red color)
Number of subjects: 74
Study: 34044603

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with multidisciplinary care
Number of subjects: 20
Study: 32016386

Group type: EXPERIMENTAL
Intervention: 5 mg intravenous zoledronate (ZZ, n = 16)
Number of subjects: 33

Group type: COMPARATOR
Intervention: 5 mg intravenous zoledronate at 5.5 years (PZ, n = 17)
Number of subjects: 33
Study: 34742297

Group type: EXPERIMENTAL
Intervention: Active non-invasive low-frequency nerve stimulation (LFS) for 3 months (minimum 10 min/day)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Sham non-invasive low-frequency nerve stimulation (LFS) for 3 months (minimum 10 min/day)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Mechanistic study assessing somatosensory changes in response to LFS
Number of subjects: 76
Study: 34215760

Group type: EXPERIMENTAL
Intervention: Random Forest (RF) model
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Support Vector Machine (SVM) model
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Logistic Regression (LR) model
Number of subjects: 190

Group type: COMPARATOR
Intervention: Radiologist diagnosis
Number of subjects: 190
Study: 35372875

Group type: EXPERIMENTAL
Intervention: Fish oil and/or aspirin
Number of subjects: 536

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Factors associated with AVF failure
Number of subjects: 536
Study: 35711093

Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 3547

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3547
Study: 33408073

Group type: EXPERIMENTAL
Intervention: Circulating 27‐OHC at or above the fourth quartile (?201 ng/mL)
Number of subjects: 1246

Group type: COMPARATOR
Intervention: Circulating 27‐OHC below the first quartile (<138 ng/mL)
Number of subjects: 1246
Study: 33040113

Group type: EXPERIMENTAL
Intervention: Haemoglobin
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Haemoglobin and haematocrit; mean corpuscular volume; red cell distribution width
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Haemoglobin and red blood cell count; haematocrit and red blood cell count; mean corpuscular haemoglobin and mean corpuscular haemoglobin concentration
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Red blood cell count and mean corpuscular volume; red blood cell count and red cell distribution width; red blood cell count and mean corpuscular haemoglobin
Number of subjects: 299

Group type: EXPERIMENTAL
Intervention: Ferritin level
Number of subjects: 299
Study: 34550860

Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous intensity exercise, 60 minutes/day, 6 days/week for 12 months
Number of subjects: 202

Group type: COMPARATOR
Intervention: Usual lifestyle (Control)
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous intensity exercise
Number of subjects: 202
Study: 34089503

Group type: EXPERIMENTAL
Intervention: ctDNA-guided adjuvant chemotherapy (AC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preference-sensitive ctDNA strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study: 35737565

Group type: EXPERIMENTAL
Intervention: R-CHOP14
Number of subjects: 600

Group type: COMPARATOR
Intervention: R-CHOP21
Number of subjects: 600
Study: 32071191

Group type: EXPERIMENTAL
Intervention: MRC-funded clinical trials registered in a public trials registry
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: MRC-funded clinical trials
Number of subjects: 175
Study: 36066323

Group type: EXPERIMENTAL
Intervention: 0.75% ruxolitinib cream
Number of subjects: 1249

Group type: EXPERIMENTAL
Intervention: 1.5% ruxolitinib cream
Number of subjects: 1249

Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 1249
Study: 33565041

Group type: EXPERIMENTAL
Intervention: Stereotactic radiosurgery (gamma knife)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MR-guided high intensity focused ultrasound
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intensive residential treatment for OCD
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lesion surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Deep brain stimulation (DBS)
Number of subjects: 0
Study: 33563173

Group type: EXPERIMENTAL
Intervention: Pregabalin (300 mg/day)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Gabapentin (800 mg/day)
Number of subjects: 64
Study: 33020394

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT), 15 min application, 1 min 30 s each muscular point, five muscular points in each lower limb
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (SHAM), 15 min application
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo (SHAM)
Number of subjects: 13
Study: 35984721

Group type: EXPERIMENTAL
Intervention: Microfragmented adipose tissue (MF-AT)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 118
Study: 34468882

Group type: EXPERIMENTAL
Intervention: Best-Worst Scaling (BWS) using ASCOT-Carer
Number of subjects: 1005

Group type: EXPERIMENTAL
Intervention: ASCOT-Carer profiles
Number of subjects: 1005

Group type: EXPERIMENTAL
Intervention: Generalised MNL model specifications
Number of subjects: 1005

Group type: EXPERIMENTAL
Intervention: Scale multinomial logit (S-MNL) model
Number of subjects: 1005
Study: 32152080

Group type: EXPERIMENTAL
Intervention: Tenofovir disoproxil fumarate (TDF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Morinidazole (MOR)
Number of subjects: 0
Study: 35405631

Group type: EXPERIMENTAL
Intervention: Laser auriculotherapy (10 sessions, twice a week)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 47
Study: 34555200

Group type: EXPERIMENTAL
Intervention: 11 for Health in Denmark programme (IG)
Number of subjects: 1122

Group type: EXPERIMENTAL
Intervention: 11 for Health in Denmark programme (IGPI subgroup)
Number of subjects: 1122

Group type: EXPERIMENTAL
Intervention: 11 for Health in Denmark programme (IGPA subgroup)
Number of subjects: 1122
Study: 36454969

Group type: EXPERIMENTAL
Intervention: 40Hz GENUS stimulation
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 15
Study: 34825617

Group type: EXPERIMENTAL
Intervention: Titrated group (received propofol at a rate of 1 mg/kg/min until the Observer's Assessment of Alertness/Sedation scale score reached 1 point)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Conventional group (received 2 mg/kg propofol at a rate of 250 mg/min)
Number of subjects: 160
Study: 35562711

Group type: EXPERIMENTAL
Intervention: Memantine (5 mg/day initially, increased to 20 mg/day over 4 weeks)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Memantine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 35570714

Group type: EXPERIMENTAL
Intervention: Secure imagery
Number of subjects: 265

Group type: COMPARATOR
Intervention: Anxious imagery
Number of subjects: 265

Group type: COMPARATOR
Intervention: Avoidant imagery
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Hyperactivating strategies
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Suppression strategies
Number of subjects: 265
Study: 33220217

Group type: EXPERIMENTAL
Intervention: WHISPER intervention (mobile phone intervention focusing on contraception)
Number of subjects: 882

Group type: COMPARATOR
Intervention: SHOUT control (nutrition-focused messages)
Number of subjects: 882
Study: 36153153

Group type: EXPERIMENTAL
Intervention: AVP booster dose in Group A (on schedule)
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: AVP booster dose in Group B (not on schedule for ≥2 years)
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: AVP booster doses
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: Toxin Neutralisation Assay (TNA)
Number of subjects: 596
Study: 34045160

Group type: EXPERIMENTAL
Intervention: COVID-19 pandemic impact on clinical, educational, and personal experiences
Number of subjects: 0
Study: 33339971

Group type: EXPERIMENTAL
Intervention: Hall technique (HT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional restoration (CR)
Number of subjects: 0
Study: 35189449

Group type: EXPERIMENTAL
Intervention: Tooth tissue-borne (TTB) rapid maxillary expansion appliance
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Tooth-borne (TB) rapid maxillary expansion appliance
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Bone-borne (BB) rapid maxillary expansion appliance
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 46
Study: 32449130

Group type: EXPERIMENTAL
Intervention: 500 mg/day resveratrol
Number of subjects: 66

Group type: COMPARATOR
Intervention: Matched placebo
Number of subjects: 66
Study: 33184629

Group type: EXPERIMENTAL
Intervention: Intravenous d6-α-tocopherol with 600-kcal defined liquid meal (40% fat)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Intravenous d6-α-tocopherol with 600-kcal defined liquid meal (0% fat)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Intravenous d6-α-tocopherol with 0% fat DLM followed by a 12-h fast (0% fat-fast)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Oral d3-α-tocopherol with 600-kcal defined liquid meal (40% fat)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Oral d3-α-tocopherol with 600-kcal defined liquid meal (0% fat)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Oral d3-α-tocopherol with 0% fat DLM followed by a 12-h fast (0% fat-fast)
Number of subjects: 17